In Re (#03 March 2017)

Review of Legal Regulation of Pharma Market of 2016. Outcomes in 2017

Alexander Bondar, Zoia Zamikhovska

At the beginning of 2017 our company ran a survey among clients, mostly international pharmaceutical companies and their representative offices in Ukraine, to define the main challenges of the pharmaceutical market in Ukraine of 2016. As a result, the current economic situation, low level of consumers paying capacity, currency risks, corruption and instability of the law were specified as the biggest threats on the pharmaceutical market. Basically, the last one will be the object of this article.

Pharmaceutical regulatory has probably been the shakiest legal field of recent times. At the end of 2016 key players of the pharmaceutical market, professional organizations and state authorities were challenged by a new piece of adopted legislation regarding the new mechanism of the state regulation of prices and implementation of the reimbursement of medicines.

The abstract/extract view of this article is free. Access to the full text of this article requires a subscription.

Please send subscription inquiries by:

Phone: +380 44 495-27-27

The Ukrainian Journal of Business Law

Subscribe to The Ukrainian Journal of Business Law right now and enjoy the most relevant issues on doing business in Ukraine on your device or in print.

All this for just USD 9.99 a month.


Subscribe now